Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants-Reference-Cited by-同舟云学术

Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants

Published:2021-07-08 Issue:2 Volume:385 Page:187-189
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Abu-Raddad Laith J.¹^ORCID,Chemaitelly Hiam¹,Butt Adeel A.²^ORCID

Affiliation:

1. Weill Cornell Medicine–Qatar, Doha, Qatar

2. Hamad Medical Corporation, Doha, Qatar

Funder

Biomedical Research Program and the Biostatistics, Epidemiology, and Biomathematics Research Core, both at Weill Cornell Medicine-Qatar, the Ministry of Public Health and Hamad Medical Corporation

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMc2104974

Cited by 906 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the Impact of Primary-Series Infection and Booster Vaccination on Protection against Omicron in Hong Kong: A Population-Based Observational Study;Vaccines;2024-09-05

2. Intranasal HD-Ad-FS vaccine induces systemic and airway mucosal immunities against SARS-CoV-2 and systemic immunity against SARS-CoV-2 variants in mice and hamsters;Frontiers in Immunology;2024-08-30

3. Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies;International Journal of Molecular Sciences;2024-07-26

4. Correlation between the Computed Tomography Score Severity Index, Age, Sex and Vaccination Status in Patients with COVID-19 Pneumonia at Al-bayda Medical Center, Libya 2021;المجلة الليبية العالمية;2024-06-14

5. SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines;Frontiers in Microbiology;2024-06-13